Although it is always important to consider optimizing the ocular surface for all patients to improve their vision, it is of critical importance before cataract surgery.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Although minimally invasive procedure gives hope, additional research is required.
An overview of Jesse Berry’s advice for starting and growing a social media account
Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Fast-acting efficacious options are key to treating acute inflammation
At the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.
Eye care providers must look beyond visual acuity in screening for disease.
Two studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
Currently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
Investigators find technology aids instruction of medical students
Moon Jeong Lee, MD, shares how volunteering in geriatric care shaped her career path.
Ophthalmologist outlines his journey with the procedure as a late adopter.
In cases where patients struggle with applying or tolerating eye drops, especially after previous selective laser trabeculoplasty (SLT) treatment, MicroPulse transscleral laser therapy (TLT) offers a practical solution.
A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.
The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.
Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Physicians note the impact of prism lenses can be life-changing for patients.
The treatment option can have a positive impact on quality of life for patients.
In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
The unique MOA may deliver a synergistic effect when prescribed post-surgically.
Ophthalmologists can use OCT to find the early signs of disease
FDA approval of teprotumumab as therapeutic offers hope for patients.
Maximizing refractive surgery is key to ensuring prosperous future
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.